Jupiter Hospital

Thane, India Founded: 2007 • Age: 19 yrs Listed
Multispecialty hospitals are operated as a chain in India.
Request Access
Report Incorrect Data
Page last updated

About Jupiter Hospital

Jupiter Hospital is a publicly listed company based in Thane (India) founded in 2007 by Ajay A Thakker. Multispecialty hospitals are operated as a chain in India. It operates on a HealthTech and Professional Services model. The company has 2,271 employees. Its chief executive, as recorded, is Ankit Thakker. Its website jupiterhospital.com draws about 62 thousand monthly visits. Its Indian entity Jupiter Life Line Hospitals Limited reported revenue of ₹1,542 Cr. Jupiter Hospital offers products and services including Cardiac Surgery, Bariatric Surgery, and Oncology. Its focus areas include Hospitals and Multispecialty Hospitals. Similar companies include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed similar companies have raised funding.

Company details

Jupiter Hospital is established as a leading tertiary care provider in India, offering over 30 specialty treatments across various medical fields. Services are delivered in specialized departments such as cardiac surgery, bariatric surgery, oncology, and neurology. The hospital operates in multiple locations including Thane, Pune, and Indore, focusing on a Patient first ideology. Comprehensive healthcare solutions are provided to address the diverse needs of a growing population, supported by skilled doctors and advanced infrastructure.

  • Headquarters Thane, India
  • Employees 2,271
  • Founders Ajay A Thakker
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website jupiterhospital.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Jupiter Life Line Hospitals Ltd.
Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹9,394 Cr

    JLHL · NSE

  • Share Price
    ₹287.60

    +0.37% today

  • Revenue
    ₹1,500 Cr

    FY 2025-26 · +15.2% YoY

  • EBITDA
    ₹338 Cr

    Margin 22.6%

  • Net Profit
    ₹189 Cr

    FY 2025-26 · -0.7% YoY

  • P/E (TTM)
    48.2x

    P/B 5.6x

  • ROE
    13.4%

    ROCE 15.0%

  • Debt / Equity
    0.34

    Interest cover 13.0x

  • Employee Count
    2,271

Products & Services of Jupiter Hospital

Jupiter Hospital offers a comprehensive portfolio of products and services, including Cardiac Surgery, Bariatric Surgery, and Oncology.

Cardiac Surgery
Healthcare

Cardiac surgery is provided for heart-related conditions.

Bariatric Surgery
Healthcare

Bariatric surgery is offered for weight loss solutions.

Oncology
Healthcare

Oncology services are provided for cancer treatment needs.

Apps and channels of Jupiter Hospital

its YouTube channel Jupiter Hospital has 3.09K subscribers and 30 videos.

Jupiter Hospital
YouTube 3.09K subscribers 30 videos Science & Technology
Open channel

Videos from Jupiter Hospital

The most watched videos on Jupiter Hospital's YouTube channel, Jupiter Hospital (3.09K subscribers). Click a video to play it here.

World Heart Day Podcast l Dr. Rajendra Patil l Dr. Tanmay Kulkarni l Jupiter Hospital
450 views
Jupiter Hospital Sets Benchmark with India’s First ALLIA IGS 530–Fastest Installation in South Asia
151 views
International Patient from Liberia | Bariatric Surgery | Dr. Prashant Salvi
146 views
Mr. Prakash Sharma | Neuro-rehabilitation | Dr. Amit Dhumale
139 views

More on Jupiter Hospital.

Board of directors of Jupiter Life Line Hospitals Limited (Jupiter Hospital)

Jupiter Life Line Hospitals Limited is the primary company behind Jupiter Hospital. The boards of the 3 registered companies of Jupiter Hospital currently have 13 directors; the longest-serving is Vadapatra Sayee Raghavan, appointed in 2009. 30 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vadapatra Sayee Raghavan
DIN 00008182
Director26 Sep 200917 yrs 1 moJupiter Life Line Hospitals Limited, Jupiter Hospital Projects Private Limited
Ankit Ajay Thakker
DIN 02874715
Managing Director29 Jun 201610 yrs 4 moJupiter Life Line Hospitals Limited, Jupiter Hospital Projects Private Limited
Jasmin A Patel
DIN 07261550
Director25 Sep 20188 yrs 1 moJupiter Life Line Hospitals Limited, Jupiter Hospital Projects Private Limited
Darshan Hiralal Vora
DIN 08207080
Director25 Sep 20188 yrs 1 moJupiter Life Line Hospitals Limited
Ajay Pratap Thakker
DIN 00120887
Designated Partner03 May 20197 yrs 6 moWestern Medical Solutions Llp, Jupiter Life Line Hospitals Limited
Kirtika Ajay Thakker
DIN 00120809
Designated Partner03 May 20197 yrs 6 moWestern Medical Solutions Llp
Devang Vasantlal Gandhi
DIN 00319483
Designated Partner03 May 20197 yrs 6 moWestern Medical Solutions Llp
Rajesh Kasliwal
DIN 00125317
Managing Director01 Sep 20206 yrs 2 moJupiter Hospital Projects Private Limited
Shrirang Ravindra Rane
DIN 00222823
Director04 Feb 20215 yrs 9 moJupiter Hospital Projects Private Limited
Satish Utekar
DIN 08385270
Director21 Feb 20233 yrs 8 moJupiter Life Line Hospitals Limited
Urmi Ashvin Popat
DIN 10047924
Director21 Feb 20233 yrs 8 moJupiter Life Line Hospitals Limited
Amar Harishchandra Manjrekar
DIN 00463989
Director09 Aug 20242 yrs 2 moJupiter Life Line Hospitals Limited
Sivasis Salilkumar Sen
DIN 09721802
CFO12 May 20251 yr 5 moJupiter Hospital Projects Private Limited

People of Jupiter Hospital

5 people are tracked at Jupiter Hospital (5 in leadership); the tracked headcount is 2,271.

NameRoleGroup
Ajay A Thakker
Founder & Managing DirectorLeadership
Ankit Thakker
CEOLeadership
Rajendra P Patankar
CEOLeadership
Dr. Shilpa Tatake
Chief Executive OfficerLeadership
Soma Midha
Unit Head HRLeadership
Premium access

Complete people profiles for Jupiter Hospital

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Jupiter Hospital

Jupiter Hospital is a publicly listed company on the NSE with ticker symbol JLHL in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date18 Sep 2023
  • Listed onNSE: JLHL · BSE: 543980
  • Listed entityJupiter Life Line Hospitals Ltd.
  • Exchange sectorHealth services
  • ISININE682M01020
  • Share price₹242.00 (-0.02% on the day) · 2026-10-14
  • Market capitalisation₹7,929 Cr
  • Price to earnings42.3
  • EPS (diluted, trailing year)₹5.72
  • Dividend yield0.08%
  • Volume (last session)56,300

Financials of Jupiter Hospital

Exchange-reported figures of Jupiter Life Line Hospitals Limited, the listed company behind Jupiter Hospital (NSE: JLHL).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,500 Cr
+15.2% YoY
EBITDA
₹338 Cr
+12.8% YoY
Profit After Tax
₹189 Cr
-0.6% YoY
Net Worth
₹1,544 Cr
+13.8% YoY
Total Assets
₹2,145 Cr
+21.8% YoY
Total Debt
₹584 Cr
+48.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,5001,3021,073893733486463
Revenue growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
EBITDA33830024219915367.1682.60
EBITDA margin+22.6%+23.0%+22.6%+22.3%+20.9%+13.8%+17.8%
Profit before tax26026119512977.091.5532.89
Net profit18919117774.0551.04(2.30)30.90
Net profit margin+12.6%+14.6%+16.5%+8.3%+7.0%-0.5%+6.7%
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
Balance sheet
Total assets2,1451,7611,172833784672509
Net worth1,5441,3561,169366294239237
Total debt5843930.00469495426272
Cash & bank58.1794.9830113410319.446.97
Net working capital(9.55)36.1028791.8485.2414.0756.79
Cash flow
Cash from operations26826711517613712374.21
Cash from investing(442)(497)(246)(94.25)(84.27)(295)(43.39)
Cash from financing136297128(51.06)32.20184(31.74)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue456411388365394353337333
Revenue growth (YoY)+16.0%+16.4%+15.2%+9.8%+17.5%+22.3%--
Other income10.5410.5910.669.1311.2712.826.887.21
EBITDA10779.2789.1677.0392.2578.4279.7076.34
EBITDA margin+23.4%+19.3%+23.0%+21.1%+23.4%+22.2%+23.7%+22.9%
Depreciation28.4826.4423.2621.7021.4621.2217.6513.99
Interest13.8312.869.017.557.848.275.612.82
Profit before tax75.0850.5667.5556.9174.2261.7563.3266.74
Tax18.7313.0517.2914.4116.7417.8018.0414.52
Net profit56.3537.5150.2642.5057.4843.9545.2852.22
EPS (₹)1.725.727.666.498.756.696.847.95
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,1981,060915787657461463
Revenue growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
EBITDA29626922720215969.0882.61
EBITDA margin+24.7%+25.4%+24.9%+25.6%+24.2%+15.0%+17.8%
Profit before tax25724620415910617.5632.90
Net profit18318015210984.4516.6029.64
Net profit margin+15.3%+17.0%+16.6%+13.8%+12.9%+3.6%+6.4%
EPS (₹)29.1928.1723.1818.9716.653.265.83
Balance sheet
Total assets1,9581,5761,247763651514499
Net worth1,6081,4231,245465329253237
Total debt3351420.00298322262263
Cash & bank40.8386.9929713310218.466.96
Net working capital12.7458.6827997.8894.5623.5371.60
Cash flow
Cash from operations23121911018414211374.60
Cash from investing(423)(455)(238)(130)(68.31)(78.22)(43.39)
Cash from financing145302122(23.22)9.66(23.43)(32.14)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue365328312291316278274270
Revenue growth (YoY)+15.5%+18.2%+14.1%+7.8%+14.8%+15.4%--
Other income6.8910.6410.109.1611.3112.847.096.89
Total expenses270259234221237210202202
EBITDA94.1269.1678.1370.0778.8267.5872.0668.68
EBITDA margin+25.8%+21.1%+25.0%+24.0%+25.0%+24.3%+26.3%+25.4%
Depreciation23.4621.5718.4716.8216.6816.6713.3810.64
Interest9.048.124.222.652.963.004.002.65
Profit before tax68.5150.1165.5459.7670.4960.7561.7762.28
Tax17.0612.9316.3415.4915.8817.4617.3412.97

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue456411388365394353337333
Revenue growth (YoY)+16.0%+16.4%+15.2%+9.8%+17.5%+22.3%--
Other income10.5410.5910.669.1311.2712.826.887.21
EBITDA10779.2789.1677.0392.2578.4279.7076.34
EBITDA margin+23.4%+19.3%+23.0%+21.1%+23.4%+22.2%+23.7%+22.9%
Depreciation28.4826.4423.2621.7021.4621.2217.6513.99
Interest13.8312.869.017.557.848.275.612.82
Profit before tax75.0850.5667.5556.9174.2261.7563.3266.74
Tax18.7313.0517.2914.4116.7417.8018.0414.52
Net profit56.3537.5150.2642.5057.4843.9545.2852.22
EPS (₹)1.725.727.666.498.756.696.847.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,5001,3021,073893733486463
Revenue growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
Other income42.3728.3522.0510.424.024.111.89
Total expenses1,1611,002831693580419380
Employee cost25622519015212910190.11
EBITDA33830024219915367.1682.60
EBITDA margin+22.6%+23.0%+22.6%+22.3%+20.9%+13.8%+17.8%
Depreciation87.6457.0842.3838.5636.1630.7425.91
Interest32.6610.7126.3442.2743.9438.9825.69
Profit before tax26026119512977.091.5532.89
Tax66.2566.9318.8055.8025.993.853.25
Net profit18919117774.0551.04(2.30)30.90
Net profit margin+12.6%+14.6%+16.5%+8.3%+7.0%-0.5%+6.7%
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital65.5765.5765.5756.5250.8750.8750.87
Reserves & surplus1,4791,2911,103309241188186
Shareholders' funds (net worth)1,5441,3561,169366294239237
Minority interest0.010.06(0.30)(1.78)(5.12)7.470.00
Secured loans5093260.00469486410254
Unsecured loans75.7167.430.000.008.9115.0717.97
Total debt5843930.00469495426272
Total liabilities2,1451,7611,172833784672509
Assets
Gross block1,7811,2901,005965891802576
Net block1,384978718720684630435
Capital work in progress12918574.0029.1526.6225.9110.50
Investments48650717.011.552.887.362.32
Inventories38.3426.4621.3419.0015.3613.0513.97
Sundry debtors75.5443.2357.2145.6927.8721.8444.61
Cash & bank balances58.1794.9830113410319.446.97
Loans & advances27.1620.7713.098.7131.1251.2265.81
Total current assets199185393208178106131
Total current liabilities20914910611692.4891.4874.57
Net working capital(9.55)36.1028791.8485.2414.0756.79
Total assets2,1451,7611,172833784672509
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash92.5226.4026.4810318.466.977.89
Net cash from operating activities26826711517613712374.21
Net cash from investing activities(442)(497)(246)(94.25)(84.27)(295)(43.39)
Net cash from financing activities136297128(51.06)32.20184(31.74)
Net change in cash(37.76)66.11(3.47)31.1084.9012.46(0.92)
Closing cash58.1794.9830113410319.446.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+15.2%+21.3%+20.3%+21.8%+50.8%+5.0%-
EBITDA growth+12.8%+24.0%+21.6%+30.0%+128.1%-18.7%-
PBT growth-0.1%+33.4%+51.9%+66.9%+4873.6%-95.3%+9997.0%
Net income growth-0.7%+7.9%+138.5%+45.1%+2319.1%-107.4%-
Revenue CAGR (3Y)+18.9%+21.1%+30.2%+24.5%---
EBITDA CAGR (3Y)+19.3%+25.1%+53.3%+34.1%---
Profitability & leverage
Net income margin+13.0%+14.9%+16.5%+8.2%+7.0%-0.5%+6.4%
Return on capital employed+15.0%+18.5%+22.1%+21.1%+16.7%+6.9%+11.5%
Return on net worth+13.4%+15.3%+23.0%+22.1%+19.2%-1.0%+12.5%
Debt / equity0.340.160.311.461.731.471.15
Long-term debt / equity0.330.150.291.391.661.401.03
Interest cover13.034.4113.1926.3337.55107.0345.32
Efficiency & per share
Fixed asset turnover0.981.131.090.960.870.710.80
Inventory turnover46.2954.4953.2251.9551.6135.9933.14
Debtors turnover25.2625.9320.8624.2729.5014.6310.38
EPS (₹)29.5929.4726.9412.9010.05(0.45)5.83
Dividend per share (₹)1.001.001.000.000.000.000.00
Book value per share (₹)235.50206.85178.3064.7057.3646.9846.54
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue365328312291316278274270
Revenue growth (YoY)+15.5%+18.2%+14.1%+7.8%+14.8%+15.4%--
Other income6.8910.6410.109.1611.3112.847.096.89
Total expenses270259234221237210202202
EBITDA94.1269.1678.1370.0778.8267.5872.0668.68
EBITDA margin+25.8%+21.1%+25.0%+24.0%+25.0%+24.3%+26.3%+25.4%
Depreciation23.4621.5718.4716.8216.6816.6713.3810.64
Interest9.048.124.222.652.963.004.002.65
Profit before tax68.5150.1165.5459.7670.4960.7561.7762.28
Tax17.0612.9316.3415.4915.8817.4617.3412.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,1981,060915787657461463
Revenue growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
Other income42.2528.0725.6913.303.754.031.89
Total expenses902791687585498392380
Employee cost19617715912911410092.75
EBITDA29626922720215969.0882.61
EBITDA margin+24.7%+25.4%+24.9%+25.6%+24.2%+15.0%+17.8%
Depreciation68.6342.4130.5228.6127.6627.3825.91
Interest12.848.6118.6627.7129.2328.1725.69
Profit before tax25724620415910617.5632.90
Tax65.1561.6451.8751.6621.040.963.26
Net profit18318015210984.4516.6029.64
Net profit margin+15.3%+17.0%+16.6%+13.8%+12.9%+3.6%+6.4%
EPS (₹)29.1928.1723.1818.9716.653.265.83
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital65.5765.5765.5756.5250.8750.8750.87
Reserves & surplus1,5421,3571,180409276202186
Shareholders' funds (net worth)1,6081,4231,245465329253237
Secured loans26175.000.00298322262254
Unsecured loans74.0867.430.000.000.000.008.59
Total debt3351420.00298322262263
Total liabilities1,9581,5761,247763651514499
Assets
Gross block1,453977731700660595576
Net block1,123713477476465426435
Capital work in progress11316361.1016.2413.8613.3310.50
Investments58060611195.4470.8665.342.33
Inventories28.5118.1716.7715.4913.3011.5313.97
Sundry debtors67.1437.7846.3540.0327.6520.4344.61
Cash & bank balances40.8386.9929713310218.466.96
Loans & advances49.0732.076.546.6230.4950.7280.63
Total current assets186175367195174101146
Total current liabilities17311688.3197.5779.0477.6174.57
Net working capital12.7458.6827997.8894.5623.5371.60
Total assets1,9581,5761,247763651514499
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash84.5418.9825.3410218.466.967.89
Net cash from operating activities23121911018414211374.60
Net cash from investing activities(423)(455)(238)(130)(68.31)(78.22)(43.39)
Net cash from financing activities145302122(23.22)9.66(23.43)(32.14)
Net change in cash(47.11)65.56(6.36)31.1583.7011.50(0.93)
Closing cash40.8386.9929713310218.466.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+13.0%+15.9%+16.2%+19.8%+42.6%-0.4%-
EBITDA growth+9.8%+18.5%+12.6%+27.1%+130.0%-16.4%-
PBT growth+4.1%+20.9%+28.3%+50.3%+502.0%-46.6%+66.7%
Net income growth+1.6%+18.4%+40.0%+28.5%+408.7%-44.0%-
Revenue CAGR (3Y)+15.0%+17.3%+25.6%+19.4%+18.2%+12.9%-
EBITDA CAGR (3Y)+13.6%+19.2%+48.7%+34.7%+34.7%+8.2%-
Profitability & leverage
Net income margin+16.0%+17.4%+16.6%+13.6%+12.9%+3.6%+6.4%
Return on capital employed+15.3%+18.1%+22.1%+26.4%+23.2%+9.0%+12.1%
Return on net worth+12.6%+13.9%+17.8%+27.0%+29.1%+6.8%+13.2%
Debt / equity0.160.050.170.781.001.071.14
Long-term debt / equity0.150.050.170.750.961.021.06
Interest cover5.653.799.4815.9922.2867.5545.31
Efficiency & per share
Fixed asset turnover0.991.241.281.161.050.790.82
Inventory turnover51.3160.6856.7054.6952.9436.1638.29
Debtors turnover22.8325.2021.1823.2727.3414.1813.13
EPS (₹)29.1928.1723.1818.9716.653.265.83
Dividend per share (₹)1.001.001.000.000.000.000.00
Book value per share (₹)245.18216.96189.9282.2864.3049.8046.54

Similar companies to Jupiter Hospital

Jupiter Hospital has 3 listed similar companies in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Fortis Healthcare
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
Ujala Cygnus
ujalacygnus.com2011Delhi, India$36.74M2,084
A chain of multi-specialty hospitals is operated in India.
Narayana Health
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Premium access

Detailed similar companies of Jupiter Hospital

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Jupiter Hospital

The website of Jupiter Hospital (jupiterhospital.com) receives about 62.2K visits a month.

  • Monthly visits
    62.2K

    ▼ 30.9% vs previous month

Similar websites

Websites whose visitors overlap most with Jupiter Hospital. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hindujahospital.com
hindujahospital.com
100%
#195,722–
rubyhall.com
rubyhall.com
95%
#697,210–
Jehangir Hospital
jehangirhospital.com
95%
43K#520,354View details
Sancheti Hospital
sanchetihospital.org
95%
14.6K#941,480View details
Poona Hospital and Research Centre
poonahospital.org
93%
15.2K#1,483,785View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Jupiter Hospital

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as Jupiter Hospital (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M321
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jupiter Hospital

JLHL: Q2 REVENUE 4.56B RUPEES VS 3.94B (YOY)
Exchange Update • 16 days ago
JLHL: Q2 CONS NET PROFIT 562M RUPEES VS 575M (YOY)
Exchange Update • 16 days ago
JLHL: Q2 EBITDA 1.07B RUPEES VS 922M (YOY); Q2 EBITDA MARGIN 23.41% VS 23.44% (YOY)
Exchange Update • 16 days ago
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26% in 1 year, according to analysts - The Economic Times
Economic Times • 1 month ago
Jupiter Life Line Hospitals: To Hold Analyst And Investor Meeting On September 28 At 1 PM
Exchange Update • 1 month ago
Buy Jupiter Life Line Hospitals; target of Rs 360: Prabhudas Lilladher
Moneycontrol • 3 months ago
JLHL: Q1 FY27 delivered solid revenue and margins, with Dombivli ramping up and expansion progressing
Quartr • 3 months ago
Jupiter Life Line Hospitals drops after Q1 PAT tumbles 15% YoY to Rs 37 cr | Capital Market News - Business Standard
Business Standard • 3 months ago
Q1 results 2026: ITC to Maruti Suzuki, Sun Pharma, among companies to declare Q1 earnings today; full list here
Mint • 3 months ago
JLHL: Q1FY27 revenue rose 16.2% year-over-year, but PAT fell 14.7% amid expansion costs
Quartr • 3 months ago
Premium access

Complete news archive for Jupiter Hospital

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jupiter Hospital

Jupiter Hospital was founded in 2007.

Jupiter Hospital is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.

Ankit Thakker is the CEO of Jupiter Hospital, as recorded in our data.

Jupiter Hospital has 2,271 employees.

The primary company behind Jupiter Hospital, Jupiter Life Line Hospitals Limited, reported revenue of ₹1,542 Cr for FY 2026, up 15% year on year.

Jupiter Hospital is established as a leading tertiary care provider in India, offering over 30 specialty treatments across various medical fields. Services are delivered in specialized departments such as cardiac surgery, bariatric surgery, oncology, and neurology. The hospital operates in multiple locations including Thane, Pune, and Indore, focusing on a Patient first ideology. Comprehensive healthcare solutions are provided to address the diverse needs of a growing population, supported by skilled doctors and advanced infrastructure.

Jupiter Hospital's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.

Jupiter Hospital offers Cardiac Surgery, Bariatric Surgery, and Oncology.

Yes, Jupiter Hospital is publicly traded on NSE under the ticker symbol JLHL.

Jupiter Hospital is associated with 3 legal entities: Jupiter Life Line Hospitals Limited, Western Medical Solutions Llp, Jupiter Hospital Projects Private Limited.

The legal entities of Jupiter Hospital currently have 16 directors, including Ajay Pratap Thakker, Kirtika Ajay Thakker, Devang Vasantlal Gandhi and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available